From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,575,692 shares, representing 4.52% for $11 million under the buyback announced on December 20, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.9 USD | +1.87% |
|
+12.39% | -25.19% |
06-25 | Zevra Therapeutics, Inc. Expands Executive Leadership Team | CI |
06-04 | Zevra Therapeutics Files $350 Million Mixed-Shelf; Shares Fall After Hours | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.19% | 205M | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Tranche Update on Zevra Therapeutics, Inc.'s Equity Buyback Plan announced on December 20, 2021.